349 related articles for article (PubMed ID: 27231849)
1. Exosomal cancer immunotherapy is independent of MHC molecules on exosomes.
Hiltbrunner S; Larssen P; Eldh M; Martinez-Bravo MJ; Wagner AK; Karlsson MC; Gabrielsson S
Oncotarget; 2016 Jun; 7(25):38707-38717. PubMed ID: 27231849
[TBL] [Abstract][Full Text] [Related]
2. Tumor cell-derived exosome-targeted dendritic cells stimulate stronger CD8+ CTL responses and antitumor immunities.
Yao Y; Chen L; Wei W; Deng X; Ma L; Hao S
Biochem Biophys Res Commun; 2013 Jun; 436(1):60-5. PubMed ID: 23707941
[TBL] [Abstract][Full Text] [Related]
3. Enhanced suppression of polyclonal CD8
Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
[TBL] [Abstract][Full Text] [Related]
4. Introduction of the CIITA gene into tumor cells produces exosomes with enhanced anti-tumor effects.
Lee YS; Kim SH; Cho JA; Kim CW
Exp Mol Med; 2011 May; 43(5):281-90. PubMed ID: 21464590
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of Anti-Leukemia Immunity by Leukemia-Derived Exosomes Via Downregulation of TGF-β1 Expression.
Huang F; Wan J; Hu W; Hao S
Cell Physiol Biochem; 2017; 44(1):240-254. PubMed ID: 29130994
[TBL] [Abstract][Full Text] [Related]
6. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
Hao S; Yuan J; Xiang J
J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
Xie Y; Zhang H; Li W; Deng Y; Munegowda MA; Chibbar R; Qureshi M; Xiang J
J Immunol; 2010 Nov; 185(9):5268-78. PubMed ID: 20881190
[TBL] [Abstract][Full Text] [Related]
8. Harnessing the exosome-induced immune response for cancer immunotherapy.
Gehrmann U; Näslund TI; Hiltbrunner S; Larssen P; Gabrielsson S
Semin Cancer Biol; 2014 Oct; 28():58-67. PubMed ID: 24859748
[TBL] [Abstract][Full Text] [Related]
9. Exosomes derived from Rab27a‑overexpressing tumor cells elicit efficient induction of antitumor immunity.
Li W; Mu D; Tian F; Hu Y; Jiang T; Han Y; Chen J; Han G; Li X
Mol Med Rep; 2013 Dec; 8(6):1876-82. PubMed ID: 24146068
[TBL] [Abstract][Full Text] [Related]
10. Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomes.
Gehrmann U; Hiltbrunner S; Georgoudaki AM; Karlsson MC; Näslund TI; Gabrielsson S
Cancer Res; 2013 Jul; 73(13):3865-76. PubMed ID: 23658368
[TBL] [Abstract][Full Text] [Related]
11. The immunogenicity of dendritic cell-derived exosomes.
Quah BJ; O'Neill HC
Blood Cells Mol Dis; 2005; 35(2):94-110. PubMed ID: 15975838
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
[TBL] [Abstract][Full Text] [Related]
13. TLR-3 stimulation improves anti-tumor immunity elicited by dendritic cell exosome-based vaccines in a murine model of melanoma.
Damo M; Wilson DS; Simeoni E; Hubbell JA
Sci Rep; 2015 Dec; 5():17622. PubMed ID: 26631690
[TBL] [Abstract][Full Text] [Related]
14. MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways.
Buschow SI; Nolte-'t Hoen EN; van Niel G; Pols MS; ten Broeke T; Lauwen M; Ossendorp F; Melief CJ; Raposo G; Wubbolts R; Wauben MH; Stoorvogel W
Traffic; 2009 Oct; 10(10):1528-42. PubMed ID: 19682328
[TBL] [Abstract][Full Text] [Related]
15. Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice.
Wang L; Xie Y; Ahmed KA; Ahmed S; Sami A; Chibbar R; Xu Q; Kane SE; Hao S; Mulligan SJ; Xiang J
Breast Cancer Res Treat; 2013 Jul; 140(2):273-84. PubMed ID: 23881522
[TBL] [Abstract][Full Text] [Related]
16. Efficient induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cells.
Chen W; Wang J; Shao C; Liu S; Yu Y; Wang Q; Cao X
Eur J Immunol; 2006 Jun; 36(6):1598-607. PubMed ID: 16708399
[TBL] [Abstract][Full Text] [Related]
17. Exosomes: a new delivery system for tumor antigens in cancer immunotherapy.
Cho JA; Yeo DJ; Son HY; Kim HW; Jung DS; Ko JK; Koh JS; Kim YN; Kim CW
Int J Cancer; 2005 Apr; 114(4):613-22. PubMed ID: 15609328
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell-derived exosomes need to activate both T and B cells to induce antitumor immunity.
Näslund TI; Gehrmann U; Qazi KR; Karlsson MC; Gabrielsson S
J Immunol; 2013 Mar; 190(6):2712-9. PubMed ID: 23418627
[TBL] [Abstract][Full Text] [Related]
19. Personalized medicine and back-allogeneic exosomes for cancer immunotherapy.
Samuel M; Gabrielsson S
J Intern Med; 2021 Feb; 289(2):138-146. PubMed ID: 31359504
[TBL] [Abstract][Full Text] [Related]
20. Poly(I:C) enhanced anti-cervical cancer immunities induced by dendritic cells-derived exosomes.
Chen S; Lv M; Fang S; Ye W; Gao Y; Xu Y
Int J Biol Macromol; 2018 Jul; 113():1182-1187. PubMed ID: 29427678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
